Cox regression analysis of prognostic factors for survival after relapse
| Factor . | RR . | 95% CI . |
|---|---|---|
| Donor type | ||
| HLA-identical sibling | 1 | |
| Volunteer unrelated | 1.58 | 1.07-2.30 |
| Disease phase at SCT | ||
| 1st CP | 1 | |
| >1st CP | 2.03 | 1.60-2.56 |
| Interval from Dx to SCT | ||
| <2 yr | 1 | |
| ≥2 yr | 1.40 | 1.11-1.76 |
| Interval from SCT to relapse | ||
| ≥1 yr | 1 | |
| <1 yr | 2.28 | 1.82-2.87 |
| Disease stage at relapse | ||
| CYT or HCP | 1 | |
| HAP | 3.08 | 2.41-3.88 |
| Factor . | RR . | 95% CI . |
|---|---|---|
| Donor type | ||
| HLA-identical sibling | 1 | |
| Volunteer unrelated | 1.58 | 1.07-2.30 |
| Disease phase at SCT | ||
| 1st CP | 1 | |
| >1st CP | 2.03 | 1.60-2.56 |
| Interval from Dx to SCT | ||
| <2 yr | 1 | |
| ≥2 yr | 1.40 | 1.11-1.76 |
| Interval from SCT to relapse | ||
| ≥1 yr | 1 | |
| <1 yr | 2.28 | 1.82-2.87 |
| Disease stage at relapse | ||
| CYT or HCP | 1 | |
| HAP | 3.08 | 2.41-3.88 |
RR indicates risk ratio; CI, confidence interval; Dx, diagnosis; SCT, stem cell transplantation; CP, chronic phase; CYT, cytogenetic relapse; HCP, hematologic relapse in CP; HAP, hematologic relapse in advanced phase (ie, accelerated phase or blastic phase).